Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Share-based Compensation (2016 - 2026)

Angiodynamics' Share-based Compensation history spans 17 years, with the latest figure at $2.7 million for Q1 2026.

  • For Q1 2026, Share-based Compensation rose 11.93% year-over-year to $2.7 million; the TTM value through Feb 2026 reached $11.7 million, up 16.55%, while the annual FY2025 figure was $9.8 million, 7.19% down from the prior year.
  • Share-based Compensation reached $2.7 million in Q1 2026 per ANGO's latest filing, down from $2.9 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $4.5 million in Q3 2025 to a low of $1.6 million in Q2 2025.
  • Average Share-based Compensation over 5 years is $2.8 million, with a median of $2.7 million recorded in 2026.
  • Peak YoY movement for Share-based Compensation: plummeted 43.97% in 2023, then surged 44.87% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $3.4 million in 2022, then crashed by 43.97% to $1.9 million in 2023, then skyrocketed by 34.68% to $2.5 million in 2024, then rose by 14.36% to $2.9 million in 2025, then decreased by 7.16% to $2.7 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Share-based Compensation are $2.7 million (Q1 2026), $2.9 million (Q4 2025), and $4.5 million (Q3 2025).